Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man

被引:114
作者
Kleinz, MJ
Maguire, JJ
Skepper, JN
Davenport, AP
机构
[1] Univ Cambridge, Ctr Clin Invest, Clin Pharmacol Unit, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Multi Imaging Ctr, Dept Anat, Cambridge CB2 3DY, England
关键词
hypertension; G protein; receptor; myocytes; vasodilation;
D O I
10.1016/j.cardiores.2005.09.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Ghrelin is the recently identified endogenous ligand for the ghrelin receptor GHS-R1a and known to regulate growth hormone secretion and appetite. Ghrelin also is a potent vasodilator and improves cardiac performance after systemic administration. Generally, the octanoyl modification on Ser(3) has been considered essential for biological activity. Recently however, cardiovascular actions of des-octanoyl ghrelin have been reported in rodents. Our aim was to investigate if ghrelin and ghrelin receptor protein are expressed within the human vasculature, to determine if des-octanoyl ghrelin, like ghrelin, is a vasodilator in human artery and to test the acute effect of ghrelin peptides on cardiac contractility. Methods: Distribution of ghrelin and ghrelin receptor was determined using standard immunocytochemistry and confocal microscopy. Ghrelin peptides were tested for vasodilator actions in human isolated arteries and their effect on cardiac contractility was investigated in human isolated paced atria. Results: Immunoreactive ghrelin was detected in endothelial cells of human arteries and veins where it localized to intracellular vesicles but not to the Weibel-Palade bodies of the regulated pathway, suggesting constitutive ghrelin production. Specific antisera detected ghrelin receptor on vascular smooth muscle cells and cardiomyocytes. Ghrelin (pD(2)=8.60 +/- 0.1, E-max =55.8 +/- 8.9, mean +/- standard error of the mean) and des-octanoyl ghrelin (pD(2)=8.8 +/- 0.2, E-max=54.7 +/- 5.3) showed comparable (P > 0.05) endothelium independent vasodilator potency and efficacy in reversing endothelin-1 induced constriction in human artery. Neither ghrelin nor des-octanoyl ghrelin had effects on contractile force in paced atria. Conclusions: We show widespread expression of ghrelin and its cognate receptor in the human cardiovascular system with functional evidence suggesting a role for both ghrelin and the more abundant endogenous form des-octanoyl ghrelin in the paracrine regulation of vascular tone in man. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]   Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans [J].
Ariyasu, H ;
Takaya, K ;
Tagami, T ;
Ogawa, Y ;
Hosoda, K ;
Akamizu, T ;
Suda, M ;
Koh, T ;
Natsui, K ;
Toyooka, S ;
Shirakami, G ;
Usui, T ;
Shimatsu, A ;
Doi, K ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4753-4758
[3]   Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT [J].
Baldanzi, G ;
Filigheddu, N ;
Cutrupi, S ;
Catapano, F ;
Bonissoni, S ;
Fubini, A ;
Malan, D ;
Baj, G ;
Granata, R ;
Broglio, F ;
Papotti, M ;
Surico, N ;
Bussolino, F ;
Isgaard, J ;
Deghenghi, R ;
Sinigaglia, F ;
Prat, M ;
Muccioli, G ;
Ghigo, E ;
Graziani, A .
JOURNAL OF CELL BIOLOGY, 2002, 159 (06) :1029-1037
[4]   Ghrelin and reproduction: a novel signal linking energy status and fertility? [J].
Barreiro, ML ;
Tena-Sempere, M .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 226 (1-2) :1-9
[5]   Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln 14-ghrelin [J].
Bedendi, I ;
Alloatti, G ;
Marcantoni, A ;
Malan, D ;
Catapano, F ;
Ghé, C ;
Deghenghi, R ;
Ghigo, E ;
Muccioli, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 476 (1-2) :87-95
[6]   Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a [J].
Bednarek, MA ;
Feighner, SD ;
Pong, SS ;
McKee, KK ;
Hreniuk, DL ;
Silva, MV ;
Warren, VA ;
Howard, AD ;
Van der Ploeg, LHY ;
Heck, JV .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4370-4376
[7]   Identification and characterization of a new growth hormone-releasing peptide receptor in the heart [J].
Bodart, V ;
Bouchard, JF ;
McNicoll, N ;
Escher, E ;
Carriere, P ;
Ghigo, E ;
Sejlitz, T ;
Sirois, MG ;
Lamontagne, D ;
Ong, H .
CIRCULATION RESEARCH, 1999, 85 (09) :796-802
[8]   Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo [J].
Conconi, MT ;
Nico, B ;
Guidolin, D ;
Baiguera, S ;
Spinazzi, R ;
Rebuffat, P ;
Malendowicz, LK ;
Vacca, A ;
Carraro, G ;
Parnigotto, PP ;
Nussdorfer, GG ;
Ribatti, D .
PEPTIDES, 2004, 25 (12) :2179-2185
[9]   Ghrelin and energy balance: Focus on current controversies [J].
Cummings, DE ;
Foster-Schubert, KE ;
Overduin, J .
CURRENT DRUG TARGETS, 2005, 6 (02) :153-169
[10]   Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness [J].
Duxbury, MS ;
Waseem, T ;
Ito, H ;
Robinson, MK ;
Zinner, MJ ;
Ashley, SW ;
Whang, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (02) :464-468